LOGIN
TEAM
CONTACT US
COLLECTIONS
Bladder
Breast
Leukemia
Liver
Sarcoma
HOME
You need to enable JavaScript to run this app page.
Breast
BCM-15046
Model Details
Patient
PDX Model
Histology
Metastasis
Patient Treatment
Patient Information for Model: BCM-15046
Patient Information
Clinical Timeline
Color Keys:
Positive
Negative
N/A
Clinical Information at Collection
Clinical Biomarkers/Mutations at Collection
Pathology Information at Collection
Model Information for Model: BCM-15046
Model Details - Initial Implantation of Patient Tissue
Biomarkers & Mutations
Model Details - Acceptable Conditions for Passaging
Mutations (Cancer Gene Census List)
Show/Hide Columns
The number of models in this collection with mutations in the listed gene;
may include models that are not publicly available for distribution.
The number of models in this collection with mutations at the listed site;
may include models that are not publicly available for distribution.
Total mutations showing: 84
F
P
1
2
3
4
5
6
N
E
Rows Per Page
10
15
25
50
Download
Gene
Filter by Gene
Chr
Filter by Chr
Start
End
Ref
Alt
cDNA Change
Codon Change
Protein Change
TVAF
Gene Mutation Freq.
Site Mutation Freq.
Most Severe Effect
All Effects
Mutation Impact
Transcript ID
ClinVar Clinical Significance
COSMIC ID
gnomAD Non-Cancer AF
dbSNP ID
Gene Mutation Freq.
Site Mutation Freq.
Transcript ID
ClinVar Clinical Significance
COSMIC ID
dbSNP ID
AKAP9
chr7
92097327
92097330
TAGA
T
c.10373_10375del
AGA/-
p.R3458del
0.316
50
3
In-frame Deletion
In-frame Deletion
MODERATE
ENST00000356239.8
rs757087367
50
3
ENST00000356239.8
rs757087367
AR
chrX
67546514
67546514
T
TGGC
c.1418_1420dup
-/GGC
p.G473dup
0.639
48
8
In-frame Insertion
In-frame Insertion
MODERATE
ENST00000374690.9
COSV104687717
48
8
ENST00000374690.9
COSV104687717
ARID1A
chr1
26696849
26696849
G
A
c.446G>A
gGc/gAc
p.G149D
0.803
19
3
Missense Variant
Missense Variant
MODERATE
ENST00000324856.13
Uncertain_significance
COSV61376273
rs2080267760
19
3
ENST00000324856.13
Uncertain_significance
COSV61376273
rs2080267760
ATRX
chrX
77682471
77682471
C
G
c.2785G>C
Gag/Cag
p.E929Q
0.425
59
56
Missense Variant
Missense Variant
MODERATE
ENST00000373344.10
Benign
rs3088074
59
56
ENST00000373344.10
Benign
rs3088074
BARD1
chr2
214767531
214767532
CA
TG
c.1518_1519inv
caTGtg/caCAtg
p.V507M
0.653
34
24
Missense Variant
Missense Variant
MODERATE
ENST00000260947.9
COSV105837301
rs386654966
34
24
ENST00000260947.9
COSV105837301
rs386654966
BAZ1A
chr14
34800248
34800248
C
G
c.1104G>C
gaG/gaC
p.E368D
0.15
9
2
Missense Variant
Missense Variant
MODERATE
ENST00000360310.6
rs1773618060
9
2
ENST00000360310.6
rs1773618060
BCL6
chr3
187728428
187728428
T
G
c.1472A>C
cAc/cCc
p.H491P
0.249
2
1
Missense Variant
Missense Variant
MODERATE
ENST00000406870.7
0.000008562960
rs748627517
2
1
ENST00000406870.7
rs748627517
BCORL1
chrX
130013265
130013265
C
T
c.493C>T
Cgg/Tgg
p.R165W
0.194
11
2
Missense Variant
Missense Variant
MODERATE
ENST00000540052.5
0.000005804670
rs185537912
11
2
ENST00000540052.5
rs185537912
BCR
chr22
23182000
23182000
C
T
c.1040C>T
tCt/tTt
p.S347F
0.104
7
2
Missense Variant
Missense Variant
MODERATE
ENST00000305877.13
7
2
ENST00000305877.13
BCR
chr22
23314599
23314599
C
G
c.3611C>G
gCc/gGc
p.A1204G
0.05
7
2
Missense Variant
Missense Variant
MODERATE
ENST00000305877.13
COSV59925974
0.000060068300
rs56265970
7
2
ENST00000305877.13
COSV59925974
rs56265970
BIRC6
chr2
32515477
32515480
ATTC
A
c.11059_11061del
aTTCtt/att
p.L3687del
0.135
15
3
In-frame Deletion
In-frame Deletion
MODERATE
ENST00000421745.6
15
3
ENST00000421745.6
BRCA1
chr17
43091983
43091983
T
C
c.3548A>G
aAa/aGa
p.K1183R
0.047
19
1
Missense Variant
Missense Variant
MODERATE
ENST00000357654.9
Benign
COSV58784397
0.354676000000
rs16942
19
1
ENST00000357654.9
Benign
COSV58784397
rs16942
CDK12
chr17
39462615
39462618
GAGA
G
c.548_550del
gAGAag/gag
p.K183del
0.9
8
3
In-frame Deletion
In-frame Deletion
MODERATE
ENST00000447079.6
8
3
ENST00000447079.6
CHD2
chr15
92992958
92992958
G
C
c.3555G>C
atG/atC
p.M1185I
0.254
5
1
Missense Variant
Missense Variant
MODERATE
ENST00000394196.9
5
1
ENST00000394196.9
CIC
chr19
42291340
42291340
C
T
c.2572C>T
Ccc/Tcc
p.P858S
0.91
11
3
Missense Variant
Missense Variant
MODERATE
ENST00000575354.6
COSV99360636
0.000175355000
rs139895527
11
3
ENST00000575354.6
COSV99360636
rs139895527
Total mutations showing: 84
F
P
1
2
3
4
5
6
N
E
Rows Per Page
10
15
25
50
Download
CNV
There are no omics data for this model.
Histology Information for Model: BCM-15046
Patient
PDX
ER
H&E
HER2
PR
Metastasis Information for Model: BCM-15046
Patient
PDX
Abdomen
Abdominal cavity
Adrenal Gland
Anterosuperior mediastinum
Ascites
Axillary Lymph Node
Bone
Brain
CTC
Chest
Chest wall
Contralateral Breast
Fallopian tubes
Head
Hilar Node
Hip
Kidney
Leg bone
Leptomeninges
Liver
Lung
Lymph Node
Mediastinum
Metastasis Pleura
Neck
None
Other
Ovary
Pancreas
Paratracheal adenopathy
Pericardium
Peritoneal cavity
Peritoneum
Pleura
Pleural cavity
Pleural effusion
Posterior cervical nodes
Pulmonary
Retrocrural Lymph Node
SVC node
Sacral Spine
Skin
Spine
Spleen
Thymus
Patient Treatment Information for Model: BCM-15046
Event Id
Treatment
Treatment Setting
Age at Start
Age at End
Duration
Clinical Response
Pathologic Response
Reason Stopped
15
Doxorubicin, Cyclophosphamide
Neoadjuvant
33.95
34.07
44 days
Partial Response
Not Applicable
Treatment Completed
20
Paclitaxel, Carboplatin
Neoadjuvant
34.11
34.32
77 days
Progressive Disease
Not Applicable
Treatment Completed
35
Radiation Therapy (RT)
Neoadjuvant
34.37
34.5
47 days
Complete Response
Pathological Complete Response (pCR)
Treatment Completed
40
Cisplatin
Neoadjuvant
34.38
34.45
26 days
Complete Response
Pathological Complete Response (pCR)
Treatment Completed
50
Capecitabine
Adjuvant
34.78
35.27
179 days
Not Reported
Not Applicable
Treatment Completed
65
Radiation Therapy (RT)
Recurrent/Metastatic
35.78
35.85
26 days
Not Reported
Not Applicable
Treatment Completed
70
Capecitabine
Recurrent/Metastatic
35.8
35.92
44 days
Not Reported
Not Applicable
Disease Progression
75
Eribulin
Recurrent/Metastatic
35.93
35.93
Unknown
Not Reported
Not Applicable
Disease Progression
Timeout
Your session is about to expire. Click 'Stay Connected' to continue the session.
Stay Connected